Vijaya Diagnostic Centre , a leading diagnostic services provider, has announced strong financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Revenue Surge

The company reported a substantial increase in its quarterly revenue, which rose to ₹188.05 crore, marking a 20.5% growth compared to ₹156.22 crore in the same period last year. This impressive top-line growth underscores the company's expanding market presence and increasing demand for its diagnostic services.

Profitability Boost

Vijaya Diagnostic Centre's profitability showed remarkable improvement:

• EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to ₹73.50 crore from ₹61.20 crore year-over-year.
• The EBITDA margin remained robust at 39.10%, compared to 39.20% in the previous year, indicating consistent operational efficiency.
• Consolidated net profit rose significantly to ₹38.59 crore from ₹31.35 crore in the corresponding quarter of the previous year, representing a growth of 23.1%.

Financial Highlights

Operational Updates

The company's Board of Directors, in their meeting held on July 28, 2025, approved several key operational decisions:

1. Employee Stock Options: The company granted 2,500 Employee Stock Options (ESOPs) under the "VDCL Employee Stock Option Plan 2018". These options are convertible into an equal number of equity shares with a face value of ₹1 each.

2. Secretarial Auditor Appointment: M/s. Balaramakrishna & Associates, Practicing Company Secretaries, have been appointed as the Secretarial Auditor for a period of five consecutive financial years from FY 2025-26 to FY 2029-30.

3. Proposed Merger: The company is progressing with its proposed Scheme of Amalgamation, wherein Medinova Diagnostic Services Limited (a subsidiary) would merge into Vijaya Diagnostic Centre. The scheme is currently awaiting necessary regulatory approvals.

Management Commentary

While specific management comments were not provided, the strong financial performance reflects the company's continued focus on expanding its service offerings and operational efficiency. The consistent EBITDA margin demonstrates Vijaya Diagnostic Centre's ability to manage costs effectively while driving growth.

Vijaya Diagnostic Centre's robust Q1 FY26 results, characterized by double-digit growth in revenue and profitability, position the company well for continued success in the diagnostic services sector. The strategic initiatives, including the proposed merger and employee stock option grants, further underscore the company's commitment to long-term growth and value creation for stakeholders.

Vijaya Diagnostic Centre Ltd. , a prominent player in the diagnostic services sector, witnessed significant trading activity on the National Stock Exchange (NSE) today. A substantial block trade involving the company's shares caught the attention of market observers.

Block Trade Details

A block trade of approximately 230,405 shares of Vijaya Diagnostic Centre Ltd. was executed on the NSE. The transaction was valued at Rs. 23.13 crore, with each share priced at Rs. 1,004.00. This sizeable trade underscores the continued interest in the company's stock among institutional investors and large traders.

Market Impact

Block trades of this magnitude often indicate a shift in ownership or a strategic move by large shareholders. While the identities of the buyer and seller remain undisclosed, such transactions can sometimes influence market sentiment and the stock's trading pattern in the short term.

About Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd. is known for providing a wide range of diagnostic and related healthcare tests and services in India. The company operates a network of diagnostic centers, offering various medical testing services to patients and healthcare providers.

Investor Considerations

Investors and market analysts will likely keep a close eye on any potential disclosures or announcements from Vijaya Diagnostic Centre Ltd. in the coming days. Such large trades can sometimes precede significant corporate actions or reflect changing perspectives on the company's future prospects.

It's important to note that while this block trade represents a notable transaction, investors should always consider a company's fundamentals, industry trends, and overall market conditions when making investment decisions.